Stock Price Quote

METROPOLIS HEALTHCARE LTD.

NSE : METROPOLISBSE : 542650ISIN CODE : INE112L01020Industry : Hospital & Healthcare ServicesHouse : Metropolis
BSE1864.856.7 (+0.36 %)
PREV CLOSE ( ) 1858.15
OPEN PRICE ( ) 1832.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4442
TODAY'S LOW / HIGH ( )1832.75 1876.90
52 WK LOW / HIGH ( )1383.7 2306.85
NSE1866.006.6 (+0.35 %)
PREV CLOSE( ) 1859.40
OPEN PRICE ( ) 1859.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1866.00 (7)
VOLUME 125743
TODAY'S LOW / HIGH( ) 1842.20 1880.00
52 WK LOW / HIGH ( )1315 2318.3
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 10-11 2000
Management Info
Sushil Shah - Chairman Surendran Chemmenkotil - Managing Director
Registered Office

Address 4th Floor, East Wing, Plot-254 B,Nirlon House, Dr. Annie Besant Road,Worli,
Mumbai,
Maharashtra-400030

Phone 022 6258 2810 / 8422 801 801

Email support@metropolisindia.com / secretarial@metropolisindia.com

Website www.metropolisindia.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

02Jul Metropolis Healthcare informs about di
Metropolis Healthcare has informed that it enclosed disclosure under Reg..
20Jun Announcement under Regulation 30 (LOD
Appointment of Dr. Monika Prabhakar as Group Head - Lab Operations
18Jun Metropolis Healthcare rises as its arm
Metropolis Healthcare is currently trading at Rs. 1699.05, up by 6.85 po..
17Jun Metropolis Healthcare’s arm acquires e
Metropolis Healthcare’s subsidiary -- Scientific Metropolis Pathology ha..
17Jun Metropolis Healthcare informs about up
In continuation to intimation dated May 31, 2025, Metropolis Healthcare..

Financials

in Millions
QTR Mar 25 ANNUAL 25
Net Profit238.51247.97
Gross Profit 286.34 1620.24
Operating Profit 603.362851.73
Net Sales 3119.5312165.43

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Krsnaa Diagnostics (BSE)
peergroup  779.60 (5.35%)
M.Cap ( in Cr)2528.92
Dr Agarwals Eye Hsp (BSE)
peergroup  4479.30 (0.72%)
M.Cap ( in Cr)2105.27
Kovai Medical Center (BSE)
peergroup  6180.35 (0.44%)
M.Cap ( in Cr)6762.70
Dr. Lal Pathlabs (BSE)
peergroup  2880.40 (0.94%)
M.Cap ( in Cr)24130.70
Yatharth Hospital (BSE)
peergroup  627.30 (3.70%)
M.Cap ( in Cr)6044.31

Shareholding Pattern

NON-INSTITUTION 5.52%
PROMOTERS 48.89%
FI/BANKS/INSURANCE 3.75%
MUTUAL FUNDS/UTI 26.42%
GOVERNMENT 0%
FII 0%

About Metropolis Healthcare Ltd.

Metropolis Healthcare Ltd. was incorporated in the year 2000. Its today's share price is 1864.85. Its current market capitalisation stands at Rs 9660.27 Cr. In the latest quarter, company has reported Gross Sales of Rs. 11034.25 Cr and Total Income of Rs.11154.22 Cr. The company's management includes Surendran Chemmenkotil, Rehan Khan, Purvi Sheth, Kamlesh Kulkarni, Aparna Rajadhyaksha, Hemant Sachdev, Subramanian Ranganathan, Sanjay Bhatnagar, Vivek Gambhir, Ameera Shah, Sushil Shah.

It is listed on the BSE with a BSE Code of 542650 , NSE with an NSE Symbol of METROPOLIS and ISIN of INE112L01020. It's Registered office is at 4th Floor, East Wing, Plot-254 B,Nirlon House, Dr. Annie Besant Road,WorliMumbai-400030, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co LLP, Walker Chandiok & Co LLP, Walker, Chandiok & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.